Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population.

@article{Ma2013RiskFF,
  title={Risk factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia in a Chinese population.},
  author={H M Ma and Margaret Ip and Jean Woo and David Shu-cheong Hui and Grace Chung Yan Lui and Nelson Lee and Paul Kay-Sheung Chan and Timothy H. Rainer},
  journal={QJM : monthly journal of the Association of Physicians},
  year={2013},
  volume={106 9},
  pages={
          823-9
        }
}
  • H. M. Ma, M. Ip, +5 authors T. Rainer
  • Published 1 September 2013
  • Medicine, Biology
  • QJM : monthly journal of the Association of Physicians
BACKGROUND The relationship between healthcare-associated pneumonia (HCAP) and resistant bacteria is unclear. The aim of this study was to identify the risk factors for pneumonia caused by drug-resistant bacteria (DRB). METHODS A prospective cohort study was conducted at a tertiary teaching hospital in Hong Kong. Consecutive older patients (aged ≥65 years) were hospitalized with pneumonia from January 2004 to June 2005. DRB comprised methicillin-resistant Staphylococcus aureus (MRSA… 
View on PubMed
academic.oup.com
12 Citations
Background Citations
1

12 Citations

Citation Type

Citation Type

A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study
TLDR
The data support inclusion of HCAP within nosocomial pneumonia guidelines and the recommendation that empiric antibiotic regimens for HCAP should be similar to those for HAP and VAP, and little difference in frequencies of Pseudomonas and Acinetobacter are found.
Isolation of ESBL-producing Bacteria from Sputum in Community-acquired Pneumonia or Healthcare-associated Pneumonia Does Not Indicate the Need for Antibiotics with Activity against This Class
TLDR
ESBL-producing bacteria isolated from sputum are not likely to be the actual causative organisms of pneumonia, however, 13 of 15 patients showed improvement of pneumonia following the initial antibiotic treatment.
Regional differences in antibiotic‐resistant pathogens in patients with pneumonia: Implications for clinicians
Antibiotic resistance is of great concern for both infection control and the treatment of infectious diseases. Previous studies reported that the occurrence of drug‐resistant pathogens (DRPs)—for…
High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia
TLDR
Until reliable molecular diagnostics are available, additional development and validation of decision support models integrating local resistance rates, estimated DRP risk, severity, and threshold for anti-DRP antibiotics are needed.
INVITED REVIEW SERIES: RESPIRATORY INFECTIONS IN THE ASIA-PACIFIC REGION
  • 2017
The respiratory threat posed by multidrug resistant Gram‐negative bacteria
TLDR
Prevalence of multidrug‐resistant Gram‐negative bacteria in different respiratory infections and their impact on clinical outcomes are highlighted, while GNB antibiotic resistance and the absence of new antibiotics are a major concern given limited treatment options.
Development and validation of a clinical risk score for predicting drug‐resistant bacterial pneumonia in older Chinese patients
TLDR
A clinical risk score for predicting drug‐resistant bacterial pneumonia in older patients is developed and validated and it is shown that bronchiectasis, recent hospitalization and severe pneumonia were independent predictors of pneumonia caused by potentially drug‐ resistant (PDR) pathogens.
Effects of Chengqi Decoction on Complications and Prognosis of Patients with Pneumonia-Derived Sepsis: Retrospective Cohort Study
TLDR
Chengqi decoction improved 28-day survival and reduced the prevalence of abdominal distension in patients with pneumonia-derived sepsis.
Antibiotic-Resistant Community-Acquired Bacterial Pneumonia.
  • J. Ho, M. Ip
  • Medicine
    Infectious disease clinics of North America
  • 2019
...
1
2
...

References

SHOWING 1-10 OF 19 REFERENCES
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.
TLDR
Although resistance is common in HCAP, not all component criteria for HCAP convey similar risk, and simple scoring tools may facilitate more accurate identification of persons with pneumonia caused by resistant pathogens.
Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.
TLDR
Risk factors for acquiring MDR bacteria should be weighted differently, and a probabilistic approach to identifying resistant pathogens among patients coming from the community with pneumonia should be embraced.
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.
  • A. Shorr, M. Zilberberg, +5 authors M. Kollef
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
TLDR
A previously developed score for determining the risk for an RO and the definition of healthcare-associated pneumonia were validated to help identify patients infected with ROs and could lead to fewer patients unnecessarily receiving broad-spectrum antibiotics.
Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens
Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience
TLDR
The study found that the incidence of HCAP was greater than that of CAP among patients with culture-positive pneumonia requiring hospitalization at Barnes-Jewish Hospital, and patients with HCAP were more likely to initially receive inappropriate antimicrobial treatment and had a greater risk of hospital mortality.
Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia.
TLDR
It is concluded that antimicrobial therapy should be targeted toward "nosocomial" pathogens in those institutionalized patients who received prior antibiotic treatment, and direct visualization of the tracheobronchial tree might be useful in determining the presence of bacterial pneumonia.
Etiology of severe pneumonia in the very elderly.
TLDR
Activity of Daily Living Index, pulmonary, endocrine and central nervous system (CNS) comorbidities were associated with distinct microbial etiology, and hospital mortality was associated independently with 24-h urine output.
Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia
TLDR
An algorithm for empiric therapy of HCAP is developed, which suggests that not all such patients require a broad-spectrum multidrug regimen in order to achieve appropriate and effective therapy.
Should nursing home-acquired pneumonia be treated as nosocomial pneumonia?
Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.
TLDR
Compared with CAP, non-CAP was associated with more severe disease, higher mortality rate, greater LOS, and increased cost, and the present analysis justified HCAP as a new category of pneumonia.
...
1
2
...